MARKET WIRE NEWS

MindBio Deploys Engineers to South American Mining Industry, Accelerates Investment in Enterprise Voice AI Health Diagnostics.

Source: TheNewsWire

(TheNewswire)

Vancouver, British Columbia –TheNewswire - February 4, 2026 MindBio Therapeutics Corp.(CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the“Company” or “MindBio”), is pleasedto report following its recent success in meeting with mining andhealth executives in South America, it has deployed a team of softwareengineers to the mining industry in country. The team deployed will beworking with health and mining officials to build a protocol forpractical implementation of drug and alcohol screening by voice. 

The voice analytics enterprise solution being developedby MindBio’s engineers is a game changer for intoxication detectionin the mining industry, aviation and construction and wherehigh-volume testing at scale for a variety of drugs and alcoholpresents major challenges for management and law enforcement, is timeconsuming, physically invasive and expensive.  

The Company’s CEO Justin Hanka said, “MindBio isseizing its first mover advantage in voice activated AI digital healthdiagnostics by investing heavily to develop scalable solutions forworkplace health and safety related to drug and alcohol intoxication.We are excited by the response we have received and look to provide asolution to the mining industry initially in Chile and then morebroadly in South America and globally”.

National work force studies in Chile alone, show thatalcohol consumption among mining workers exceeds 75 per cent and theproportion of problem drinkers is above 40 per cent with drug useestimated in 9 per cent of the more than 200,000 mining workers in thecountry (ACHS, 2012: SENDA, 2024). Internationally more than 20 to 25per cent of all occupational accidents are directly or indirectlylinked to substance use (International Labour Organization 1996, 2022:Gomez et al., 2002). This translates to tens of thousands ofpreventable workplace incidents related to drug and alcoholintoxication, creating a large potential market for the Company’s AlPlatform.

 

About MindBio TherapeuticsCorp

MinBio is a biotechnology companythat conducts clinical health research and has developed a world firstAI prediction tool for drug and alcohol intoxication detection by asimple analysis of the voice. The AI prediction model uses over 50million data points to predict alcohol intoxication with remarkableaccuracy, just by using the human voice. The Company is now collectingdata that will allow its prediction tool to work on other types ofintoxication.

  

For further information, please contact:

 

Justin Hanka, Chief ExecutiveOfficer

61 433140886

[email protected]

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6;OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver,British Columbia, that for several years has been conducting drug andalcohol research and has created health prediction technologies usingAI and machine learning.  The Company has expertise in using speechanalytics as a prediction tool for drug and alcohol intoxication andhas created a world first voice and AI powered prediction model fordrug and alcohol intoxication for use in consumer and enterprisesituations.  The Company is developing a comprehensive enterpriseplatform using voice and powered by AI for use in detecting drug andalcohol intoxication in workplaces, law enforcement, mental health andtelehealth.

Cautionary Note ConcerningForward-Looking Statements:

The press release contains "forward-lookingstatements" within the meaning of applicable securities laws.Forward-looking statements can be identified by words such as:"anticipate," "intend," "plan,""budget," "believe," "project,""estimate," "expect," "scheduled,""forecast," "strategy," "future,""likely," "may," "to be,""could," "would," "should,""will" and similar references to future periods or thenegative or comparable terminology, as well as terms usually used inthe future and conditional. Forward-looking statements are based onassumptions as of the date they are provided. However, there can be noassurance that such assumptions will reflect the actual outcome ofsuch items or factors.

Additionally, there are known and unknown risk factorsthat could cause the Company's actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: general economic, market and business conditions in Canada andAustralia; market volatility; unforeseen delays in timelines for anyof the transactions or events described in this press release.  Allforward-looking information is qualified in its entirety by thiscautionary statement.

The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.

Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.

MindBio Therapeutics Corp

NASDAQ: MBQIF

MBQIF Trading

-1.68% G/L:

$0.6985 Last:

1,100 Volume:

$0.698455 Open:

mwn-alerts Ad 300

MBQIF Latest News

MBQIF Stock Data

$2,829,771
4,518,518
13.12%
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App